Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more
Innovotech Inc (IOT) - Total Assets
Latest total assets as of September 2025: CA$3.39 Million CAD
Based on the latest financial reports, Innovotech Inc (IOT) holds total assets worth CA$3.39 Million CAD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Innovotech Inc - Total Assets Trend (2003–2024)
This chart illustrates how Innovotech Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Innovotech Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Innovotech Inc's total assets of CA$3.39 Million consist of 52.1% current assets and 47.9% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 22.5% |
| Accounts Receivable | CA$536.07K | 16.7% |
| Inventory | CA$128.36K | 4.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$543.02K | 16.9% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Innovotech Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Innovotech Inc's current assets represent 52.1% of total assets in 2024, a decrease from 91.3% in 2003.
- Cash Position: Cash and equivalents constituted 22.5% of total assets in 2024, down from 90.0% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 16.9% of total assets.
Innovotech Inc Competitors by Total Assets
Key competitors of Innovotech Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Innovotech Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Innovotech Inc generates 0.68x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Innovotech Inc generates $6.98 in net profit.
Innovotech Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.77 | 3.33 | 4.78 |
| Quick Ratio | 4.45 | 2.91 | 4.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$1.78 Million | CA$ 526.25K | CA$ 595.26K |
Innovotech Inc - Advanced Valuation Insights
This section examines the relationship between Innovotech Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.16 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | 164.7% |
| Total Assets | CA$3.22 Million |
| Market Capitalization | $4.32 Million USD |
Valuation Analysis
Above Book Valuation: The market values Innovotech Inc's assets above their book value (1.34 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Innovotech Inc's assets grew by 164.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Innovotech Inc (2003–2024)
The table below shows the annual total assets of Innovotech Inc from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$3.22 Million | +164.68% |
| 2023-12-31 | CA$1.22 Million | -0.51% |
| 2022-12-31 | CA$1.22 Million | -14.67% |
| 2021-12-31 | CA$1.43 Million | +74.23% |
| 2020-12-31 | CA$822.44K | +199.20% |
| 2019-12-31 | CA$274.88K | +0.94% |
| 2018-12-31 | CA$272.33K | -48.35% |
| 2017-12-31 | CA$527.26K | +62.10% |
| 2016-12-31 | CA$325.27K | +52.66% |
| 2015-12-31 | CA$213.06K | -47.89% |
| 2014-12-31 | CA$408.86K | -3.39% |
| 2013-12-31 | CA$423.21K | -49.54% |
| 2003-12-31 | CA$838.70K | -4.87% |
| 2003-09-30 | CA$881.62K | -- |